Programme Thesis
The BioInnovation Institute (BII) provides pre-seed and seed funding, incubation, and business development support to translate early-stage life science and biotech innovations into commercial startups, with a new strategic emphasis on AI and quantum technologies. It exists to strengthen European competitiveness by scaling Denmark’s innovation ecosystem and bridging the gap between academic research and market-ready solutions.
Selection Criteria
• Scientific excellence and novelty of the proposed innovation
• Commercial potential and scalability of the business model
• Team’s expertise, commitment, and ability to execute
• Alignment with BII’s strategic areas (life sciences, AI, quantum)
• Feasibility of establishing a Danish or EU legal entity
• Clear milestone plan and use of funds
• Potential for societal impact and job creation in Europe
Past Winners / Cohort Profiles
BII has supported over 130 startups, attracting €937M in external funding. Typical winners are early-stage, often university-spinout teams with a strong scientific founder, a validated prototype or proof-of-concept, and a clear path to incorporation in Denmark or another EU country. Named examples were not provided on the page, but the profile includes biotech, medtech, and digital health ventures.
Ideal Candidate Fingerprint
A scientist-entrepreneur with a breakthrough innovation in life sciences or AI-driven biotech, who has a clear commercial vision and is ready to incorporate a company in Denmark or the EU. The ideal applicant has a strong track record of research, a validated prototype, and a team that combines scientific depth with business acumen.
Recommended Framing
Eniola should position his CCT model and AI-driven drug resistance prediction platform as a transformative AI-in-life-sciences venture that directly aligns with BII’s new strategic focus. He must emphasize his readiness to establish a Danish or EU entity (e.g., via a Danish incubator partnership or a co-founder with EU residency) and frame his independent research and open-source tools as evidence of entrepreneurial drive and scientific rigor, despite lacking a PhD or formal incorporation.
Watch Out
Applicant is not yet incorporated and has no EU entity; BII typically requires a Danish or EU legal entity for funding. Applicant is an independent researcher without a PhD or formal academic affiliation, which may weaken credibility against university-spinout teams. The venture is at a very early stage (pre-seed, no revenue) and the applicant is not currently based in Europe.